These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 2873704

  • 1. Drug and transmitter receptors in human brain. Characterization and localization of serotonin, dopamine and adrenergic receptors.
    Maloteaux JM.
    Acta Neurol Belg; 1986; 86(2):61-129. PubMed ID: 2873704
    [Abstract] [Full Text] [Related]

  • 2. Characterization of solubilized serotonin (S2) receptors in rat brain.
    Ilien B, Gorissen H, Laduron PM.
    Mol Pharmacol; 1982 Sep; 22(2):243-9. PubMed ID: 7144728
    [Abstract] [Full Text] [Related]

  • 3. Influence of supidimide on brain neurotransmitter systems of rats and mice.
    Hennies HH, Günzler WA, Flohé L.
    Arzneimittelforschung; 1984 Sep; 34(11):1471-80. PubMed ID: 6084511
    [Abstract] [Full Text] [Related]

  • 4. Preliminary studies of human cortical 5-HT2 receptors and their involvement in schizophrenia and neuroleptic drug action.
    Reynolds GP, Rossor MN, Iversen LL.
    J Neural Transm Suppl; 1983 Sep; 18():273-7. PubMed ID: 6135746
    [Abstract] [Full Text] [Related]

  • 5. Effect of pyridoxine deficiency in young rats on high-affinity serotonin and dopamine receptors.
    Paulose CS, Dakshinamurti K.
    J Neurosci Res; 1985 Sep; 14(2):263-70. PubMed ID: 4046074
    [Abstract] [Full Text] [Related]

  • 6. Neurotransmitter receptor alterations in Huntington's disease: autoradiographic and homogenate studies with special reference to benzodiazepine receptor complexes.
    Whitehouse PJ, Trifiletti RR, Jones BE, Folstein S, Price DL, Snyder SH, Kuhar MJ.
    Ann Neurol; 1985 Aug; 18(2):202-10. PubMed ID: 2994554
    [Abstract] [Full Text] [Related]

  • 7. Down regulation of serotonin-S2 receptor sites in rat brain by chronic treatment with the serotonin-S2 antagonists: ritanserin and setoperone.
    Leysen JE, Van Gompel P, Gommeren W, Woestenborghs R, Janssen PA.
    Psychopharmacology (Berl); 1986 Aug; 88(4):434-44. PubMed ID: 3010361
    [Abstract] [Full Text] [Related]

  • 8. Regional distribution of neurotransmitter receptors in the visual structures of the rat brain.
    Schliebs R, Estrada E, Rothe T, Aurich M, Bigl V.
    Biomed Biochim Acta; 1984 Aug; 43(10):1119-25. PubMed ID: 6098272
    [Abstract] [Full Text] [Related]

  • 9. Dopamine D2-like sites in schizophrenia, but not in Alzheimer's, Huntington's, or control brains, for [3H]benzquinoline.
    Seeman P, Guan HC, Nobrega J, Jiwa D, Markstein R, Balk JH, Picetti R, Borrelli E, Van Tol HH.
    Synapse; 1997 Feb; 25(2):137-46. PubMed ID: 9021894
    [Abstract] [Full Text] [Related]

  • 10. [Chemistry of cell surface receptors--catecholamine receptor].
    Haga T.
    Nihon Rinsho; 1979 Feb; 37(7):2725-33. PubMed ID: 231130
    [No Abstract] [Full Text] [Related]

  • 11. Postmortem neurochemistry in schizophrenia.
    Bracha HS, Kleinman JE.
    Psychiatr Clin North Am; 1986 Mar; 9(1):133-41. PubMed ID: 2421270
    [Abstract] [Full Text] [Related]

  • 12. Low density of dopamine D4 receptors in Parkinson's, schizophrenia, and control brain striata.
    Seeman P, Guan HC, Van Tol HH, Niznik HB.
    Synapse; 1993 Aug; 14(4):247-53. PubMed ID: 8248849
    [Abstract] [Full Text] [Related]

  • 13. In vitro pharmacological profile of 3-N-(2-fluoroethyl)spiperone.
    Goffinet AM, Leysen J, Labar D.
    J Cereb Blood Flow Metab; 1990 Jan; 10(1):140-2. PubMed ID: 2137131
    [Abstract] [Full Text] [Related]

  • 14. S 15535, a novel benzodioxopiperazine ligand of serotonin (5-HT)1A receptors: I. Interaction with cloned human (h)5-HT1A, dopamine hD2/hD3 and h alpha2A-adrenergic receptors in relation to modulation of cortical monoamine release and activity in models of potential antidepressant activity.
    Millan MJ, Newman-Tancredi A, Rivet JM, Brocco M, Lacroix P, Audinot V, Cistarelli L, Gobert A.
    J Pharmacol Exp Ther; 1997 Jul; 282(1):132-47. PubMed ID: 9223549
    [Abstract] [Full Text] [Related]

  • 15. Regional and cortical laminar distributions of serotonin S2, benzodiazepine, muscarinic, and dopamine D2 receptors in human brain.
    Luabeya MK, Maloteaux JM, Laduron PM.
    J Neurochem; 1984 Oct; 43(4):1068-71. PubMed ID: 6088690
    [Abstract] [Full Text] [Related]

  • 16. Biochemical and physiological evidences for antiserotonergic properties of naftidrofuryl.
    Maloteaux JM, Haiech J, De Campeneere D, Berta P, Vidal N.
    Arzneimittelforschung; 1986 Aug; 36(8):1194-8. PubMed ID: 3022761
    [Abstract] [Full Text] [Related]

  • 17. Organization of dopamine D1 and D2 receptors in human striatum: receptor autoradiographic studies in Huntington's disease and schizophrenia.
    Joyce JN, Lexow N, Bird E, Winokur A.
    Synapse; 1988 Aug; 2(5):546-57. PubMed ID: 2973147
    [Abstract] [Full Text] [Related]

  • 18. In vivo binding of [3H]ketanserin on serotonin S2-receptors in rat brain.
    Laduron PM, Janssen PF, Leysen JE.
    Eur J Pharmacol; 1982 Jun 16; 81(1):43-8. PubMed ID: 7117369
    [Abstract] [Full Text] [Related]

  • 19. Autoradiographic analysis of adrenergic receptors in the mammalian brain.
    Goffinet AM, De Volder A.
    Acta Neurol Belg; 1985 Jun 16; 85(2):82-109. PubMed ID: 2988261
    [Abstract] [Full Text] [Related]

  • 20. Contamination of serotonin-2 binding sites by an alpha-1 adrenergic component in assays with (3H)spiperone.
    Morgan DG, Marcusson JO, Finch CE.
    Life Sci; 1984 Jun 18; 34(25):2507-14. PubMed ID: 6328167
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.